⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHIO News
Phio Pharmaceuticals Corp. Common Stock
Form 8-K
sec.gov
PHIO
Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894 Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Form 8-K
sec.gov
PHIO
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Form 8-K
sec.gov
PHIO
Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors Ready to Announce with Confidence?
newsfilecorp.com
PHIO